enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Could pomegranates help aid memory and ease Alzheimer’s symptoms?

   www.aol.com/lifestyle/could-pomegranates-help...

   Alzheimer’s disease is a degenerative brain disorder that primarily affects individuals over the age of 65 and is the leading cause of dementia in older adults.

3. Could a cancer drug help treat early Alzheimer’s? Study ...

   www.aol.com/could-cancer-drug-help-treat...

   Treatment with the cancer drug restored function in the hippocampus in an Alzheimer’s mouse model. It has long been understood that glucose metabolism in the brain is disrupted by aging and ...

4. Eating More of This Fruit May Improve Memory and Alzheimer’s ...

   www.aol.com/eating-more-fruit-may-improve...

   A substance found in pomegranates may improve memory and Alzheimer’s disease symptoms, new research finds. ... memory and aid in dementia prevention and treatment. ... really establishes clear ...

5. Alzheimer's disease - Wikipedia

   en.wikipedia.org/wiki/Alzheimer's_disease

   The causes of Alzheimer's disease remain poorly understood. [16] There are many environmental and genetic risk factors associated with its development. The strongest genetic risk factor is from an allele of apolipoprotein E. [17] [18] Other risk factors include a history of head injury, clinical depression, and high blood pressure. [1]

6. Galantamine - Wikipedia

   en.wikipedia.org/wiki/Galantamine

   Galantamine is a type of acetylcholinesterase inhibitor.It is an alkaloid extracted from the bulbs and flowers of Galanthus nivalis (common snowdrop), Galanthus caucasicus (Caucasian snowdrop), Galanthus woronowii (Voronov's snowdrop), and other members of the family Amaryllidaceae, such as Narcissus (), Leucojum aestivum (snowflake), and Lycoris including Lycoris radiata (red spider lily). [5]

7. Aducanumab - Wikipedia

   en.wikipedia.org/wiki/Aducanumab

   Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.